Expanded Indications in the Pediatric BONEBRIDGE Population
Active, not recruiting · Not applicable · NCT05615649
Conditions: Hearing Loss, Conductive, Hearing Loss, Mixed
At a glance
- Research payments reported, 2025
- $376,315
- U.S. investigators named
- 5
- Sites paid
- 6
- Planned or actual enrollment
- 36
About the trial
- Sponsor
- Med-El Corporation
- Tested
- MED-EL BONEBRIDGE Bone Conduction Implant (device)
- Dates
- Started 2023-10-03; completion 2026-10
- Results posted
- Not yet
This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.
From ClinicalTrials.gov, last updated 2026-08-19. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Med-el Corporation reported $376,315 in research payments for this study in 2025 (26 payments).
Products named: Bci 602 Kit
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Sarah Gitomer, M.D. ENT (Otolaryngology) · Denver, CO
- Neil S. Patel, MD ENT (Otolaryngology) · Rochester, MN
- Anne M. Selleck, MD ENT (Otolaryngology) · Chapel Hill, NC
- Yu-lan Mary Ying, M.D. ENT (Otolaryngology) · Newark, NJ
- Jonathan M. Grischkan, MD ENT (Otolaryngology) · Columbus, OH
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Rutgers the State University $166,849
- University of Utah Hospital and Clinics, UT $100,708
- The University of North Carolina $50,018
- Children's Hospital Colorado, CO $45,177
- University of Colorado Denver $12,161
- The Research Institute at Nationwide Children's $1,400
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.